National Bank Of Canada Rigel Pharmaceuticals Inc Transaction History

National Bank Of Canada

  • $72.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023
SELL
$1.07 - $1.39 $1,070 - $1,390
-1,000 Reduced 20.0%
4,000 $4,000
Q2 2023

Jul 26, 2023
BUY
$1.12 - $1.82 $1,120 - $1,820
1,000 Added 25.0%
5,000 $6,000
Q4 2021

Jan 24, 2022
BUY
$2.36 - $3.57 $9,440 - $14,280
4,000 New
4,000 $11,000

Others Institutions Holding RIGL

# of Institutions
8
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.96B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email